EQUILLIUM, INC. Share-based Payment Arrangement, Expense
EQUILLIUM, INC. (EQ) reported Share-based Payment Arrangement, Expense of $1.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13
- EQUILLIUM, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $1.09M, a 93.25% increase year-over-year.
- EQUILLIUM, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $930.00K, a 49.76% increase year-over-year.
- EQUILLIUM, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $737.00K, a 10.23% decline year-over-year.
- EQUILLIUM, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $401.00K, a 60.10% decline year-over-year.
- EQUILLIUM, INC. share-based payment arrangement, expense for fiscal 2025 was $2.32M, a 38.08% decline from fiscal 2024.
- EQUILLIUM, INC. share-based payment arrangement, expense for fiscal 2024 was $3.75M, a 6.18% decline from fiscal 2023.
- EQUILLIUM, INC. share-based payment arrangement, expense for fiscal 2023 was $4.00M, a 17.43% decline from fiscal 2022.
- EQUILLIUM, INC. share-based payment arrangement, expense for fiscal 2022 was $4.84M, a 9.77% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 7 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.09M 10-Q · filed 2026-08-13 | $2.02M 10-Q · filed 2026-08-13 | $2.75M derived: sum of 3 quarters · filed 2026-08-13 | $3.16M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $930.00K 10-Q · filed 2026-05-13 | $1.67M derived: sum of 2 quarters · filed 2026-05-13 | $2.07M derived: sum of 3 quarters · filed 2026-05-13 | $2.63M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $737.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.14M derived: sum of 2 quarters · filed 2026-03-25 | $1.70M derived: sum of 3 quarters · filed 2026-08-13 | $2.32M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $401.00K 10-Q · filed 2025-11-13 | $964.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.58M 10-Q · filed 2025-11-13 | $2.41M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $563.00K 10-Q · filed 2026-08-13 | $1.18M 10-Q · filed 2026-08-13 | $2.00M derived: sum of 3 quarters · filed 2026-08-13 | $3.01M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $621.00K 10-Q · filed 2026-05-13 | $1.44M derived: sum of 2 quarters · filed 2026-05-13 | $2.45M derived: sum of 3 quarters · filed 2026-05-13 | $3.40M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $821.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.83M derived: sum of 2 quarters · filed 2026-03-25 | $2.78M derived: sum of 3 quarters · filed 2026-03-25 | $3.75M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $1.00M 10-Q · filed 2025-11-13 | $1.96M derived: sum of 2 quarters · filed 2025-11-13 | $2.93M 10-Q · filed 2025-11-13 | $3.98M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $952.00K 10-Q · filed 2025-08-14 | $1.92M 10-Q · filed 2025-08-14 | $2.97M derived: sum of 3 quarters · filed 2025-08-14 | $3.95M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $972.00K 10-Q · filed 2025-05-14 | $2.02M derived: sum of 2 quarters · filed 2025-05-14 | $3.00M derived: sum of 3 quarters · filed 2025-05-14 | $3.93M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.02M derived: sum of 2 quarters · filed 2025-03-27 | $2.96M derived: sum of 3 quarters · filed 2025-03-27 | $4.00M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $979.00K 10-Q · filed 2024-11-13 | $1.91M derived: sum of 2 quarters · filed 2024-11-13 | $2.95M 10-Q · filed 2024-11-13 | $4.00M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $934.00K 10-Q · filed 2024-08-08 | $1.97M 10-Q · filed 2024-08-08 | $3.02M derived: sum of 3 quarters · filed 2024-08-08 | $4.21M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $1.04M 10-Q · filed 2024-05-09 | $2.09M derived: sum of 2 quarters · filed 2024-05-09 | $3.28M derived: sum of 3 quarters · filed 2024-05-09 | $4.58M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.24M derived: sum of 2 quarters · filed 2024-03-25 | $3.54M derived: sum of 3 quarters · filed 2024-03-25 | $4.84M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | $1.19M 10-Q · filed 2023-11-08 | $2.49M derived: sum of 2 quarters · filed 2023-11-08 | $3.79M 10-Q · filed 2023-11-08 | $4.94M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $1.30M 10-Q · filed 2023-08-09 | $2.60M 10-Q · filed 2023-08-09 | $3.75M derived: sum of 3 quarters · filed 2023-08-09 | $4.90M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $1.30M 10-Q · filed 2023-05-11 | $2.45M derived: sum of 2 quarters · filed 2023-05-11 | $3.60M derived: sum of 3 quarters · filed 2023-05-11 | $4.66M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $2.30M derived: sum of 2 quarters · filed 2023-03-23 | $3.37M derived: sum of 3 quarters · filed 2023-03-23 | $4.41M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $1.15M 10-Q · filed 2022-11-14 | $2.21M derived: sum of 2 quarters · filed 2022-11-14 | $3.26M 10-Q · filed 2022-11-14 | $4.09M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.06M 10-Q · filed 2022-08-15 | $2.11M 10-Q · filed 2022-08-15 | $2.94M derived: sum of 3 quarters · filed 2022-08-15 | $3.79M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $1.04M 10-Q · filed 2022-05-12 | $1.88M derived: sum of 2 quarters · filed 2022-05-12 | $2.72M derived: sum of 3 quarters · filed 2022-05-12 | $4.07M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $833.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.68M derived: sum of 2 quarters · filed 2022-03-23 | $3.03M derived: sum of 3 quarters · filed 2022-03-23 | $3.82M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $847.00K 10-Q · filed 2021-11-10 | $2.20M derived: sum of 2 quarters · filed 2021-11-10 | $2.98M 10-Q · filed 2021-11-10 | $3.58M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $1.35M 10-Q · filed 2021-08-10 | $2.14M 10-Q · filed 2021-08-10 | $2.73M derived: sum of 3 quarters · filed 2021-08-10 | $3.36M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $787.00K 10-Q · filed 2021-05-13 | $1.38M derived: sum of 2 quarters · filed 2021-05-13 | $2.01M derived: sum of 3 quarters · filed 2021-05-13 | $2.59M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $592.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $1.23M derived: sum of 2 quarters · filed 2021-03-24 | $1.81M derived: sum of 3 quarters · filed 2021-03-24 | $2.25M 10-K · filed 2021-03-24 | ||||
| 2019-09-30 | $633.00K 10-Q · filed 2020-11-10 | $1.21M derived: sum of 2 quarters · filed 2020-11-10 | $1.66M 10-Q · filed 2020-11-10 | $1.97M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | $581.00K 10-Q · filed 2020-08-12 | $1.03M 10-Q · filed 2020-08-12 | $1.34M derived: sum of 3 quarters · filed 2020-08-12 | $1.47M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $446.00K 10-Q · filed 2020-05-13 | $757.00K derived: sum of 2 quarters · filed 2020-05-13 | $888.00K derived: sum of 3 quarters · filed 2020-05-13 | $889.00K derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $442.00K derived: sum of 2 quarters · filed 2020-03-26 | $443.00K derived: sum of 3 quarters · filed 2020-03-26 | $442.00K 10-K · filed 2020-03-26 | $441.91K 10-K · filed 2019-03-27 | |||
| 2018-09-30 | $131.00K 10-Q · filed 2019-11-12 | $100.00K 10-Q · filed 2018-11-15 | $132.00K derived: sum of 2 quarters · filed 2019-11-12 | $131.00K 10-Q · filed 2019-11-12 | $100.00K 10-Q · filed 2018-11-15 | |||
| 2018-06-30 | $1.00K 10-Q · filed 2019-08-12 | $1.00K 10-Q · filed 2019-08-12 | ||||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-15 | $0.00 10-Q · filed 2018-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |